Literature DB >> 27837546

Targeted Magnetic Liposomes Loaded with Doxorubicin.

Pallab Pradhan1,2,3, Rinti Banerjee4, Dhirendra Bahadur5, Christian Koch6, Olga Mykhaylyk6, Christian Plank6.   

Abstract

Targeted delivery systems for anticancer drugs are urgently needed to achieve maximum therapeutic efficacy by site-specific accumulation and thereby minimizing adverse effects resulting from systemic distribution of many potent anticancer drugs. We have prepared folate receptor-targeted magnetic liposomes loaded with doxorubicin, which are designed for tumor targeting through a combination of magnetic and biological targeting. Furthermore, these liposomes are designed for hyperthermia-induced drug release to be mediated by an alternating magnetic field and to be traceable by magnetic resonance imaging (MRI). Here, detailed preparation and relevant characterization techniques of targeted magnetic liposomes encapsulating doxorubicin are described.

Entities:  

Keywords:  Doxorubicin; Folate; Magnetic liposomes; Magnetic nanoparticles; Targeted

Mesh:

Substances:

Year:  2017        PMID: 27837546     DOI: 10.1007/978-1-4939-6591-5_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy.

Authors:  Buyankhishig Dorjsuren; Birendra Chaurasiya; Zixuan Ye; Yanyan Liu; Wei Li; Chaoyang Wang; Di Shi; Colin E Evans; Thomas J Webster; Yan Shen
Journal:  Int J Nanomedicine       Date:  2020-10-23

2.  Liposomes Loaded with Cisplatin and Magnetic Nanoparticles: Physicochemical Characterization, Pharmacokinetics, and In-Vitro Efficacy.

Authors:  Alfonso Toro-Cordova; Mario Flores-Cruz; Jaime Santoyo-Salazar; Ernesto Carrillo-Nava; Rafael Jurado; Pavel A Figueroa-Rodriguez; Pedro Lopez-Sanchez; Luis A Medina; Patricia Garcia-Lopez
Journal:  Molecules       Date:  2018-09-06       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.